CMMB
Chemomab TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
Nebokitug now has an unusually clear regulatory path for PSC for a company this small: single pivotal Phase 3 design, no biopsy requirement, no confirmatory study requirement, and additional FDA CMC/toxology flexibility. Combined with positive Phase 2 and OLE biomarker data, that creates asymmetric upside if Chemomab secures funding or a partner [#PR-2025-02-19] [#PR-2025-03-27] [#6-K-2026-03-19].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Further dilution remains a core risk despite runway guidance through Q1 2027.
Momentum
84
Value
41
Sentiment
63
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.50 · Bull $4.00 · Bear $0.50
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $5.00
Why
Momentum84 · Δ7d -
Value41 · Δ7d -0.1
Sentiment63 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
84
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
63
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 83.8 / Value 41.1 / Sentiment 62.6
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$11.23M
Beta
0.55
Shares Out
7.2M
P/E (TTM) · Derived
-1.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.19
Rev YoY
-
EPS YoY
-61.7%
Gross Margin
-
Op Margin
-
Net Debt
-$10.37M
Current Ratio
10.31
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology